Trial Profile
Study of effectiveness of on-demand therapy using 20mg vonoprazan for NERD (Grade M by revised LA classification) well controlled with a proton pump inhibitor (PPI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2019
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 19 Feb 2019 Status changed from recruiting to completed.
- 07 Sep 2018 New trial record